A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma

Clinical trial NCT06614855 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06614855
Sponsor: James Markert, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Glioblastoma (GBM)Astrocytoma Astrocytoma, Grade III Astrocytoma, Grade IV Gliosarcoma, Adult Gliosarcoma of Brain

Start date: 2025-06-02
Primary completion: 2027-01-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.